Innovative endoscopy for label-free optical biopsies in surgery of colorectal liver metastases and hepatocellular carcinoma

Innovative endoscopy for label-free optical biopsies in surgery of colorectal liver metastases and hepatocellular carcinoma - EOB-trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022261

Enrollment

100

Registered

2020-07-09

Start date

2020-04-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22 C78.7

Interventions

Group 1: Patients who are receiving a liver resection due to HCC or CRLM are included. The extent of resection is not expanded by the study and is only based on the medical need for the patient. Fresh

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Included are patients = 18 years of age, who receive a liver resection because of HCC or CRLM, and give their informed consent

Exclusion criteria

Exclusion criteria: speech problems or impaired mental state, lack of compliance

Design outcomes

Primary

Measure	Time frame
The aim of the project is the translation of innovative optical techniques into clinical application to increase surgical accuracy in oncological liver surgery. The project is aimed at the development of methods for the intraoperative detection of intrahepatic tumor cells using hepatocellular carcinomas or colorectal liver metastases as examples. The main focus is on the resection margins immediately after resection. Within the scope of this study, optical devices are developed and initially tested ex situ on liver tissue samples.	—

Measure

Time frame

The aim of the project is the translation of innovative optical techniques into clinical application to increase surgical accuracy in oncological liver surgery. The project is aimed at the development of methods for the intraoperative detection of intrahepatic tumor cells using hepatocellular carcinomas or colorectal liver metastases as examples. The main focus is on the resection margins immediately after resection. Within the scope of this study, optical devices are developed and initially tested ex situ on liver tissue samples.

—

Countries

Germany

Contacts

Public ContactCarina Riediger-Schweipert

Universitätsklinikum Carl-Gustav-Carus Dresden an der TU DresdenKlinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie

carina.riediger@ukdd.de+49 (0)351 458 18353

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026